Combination therapy for recurrent prostate cancer may slow progression and extend survival
CANCER DIGEST – Oct. 21, 2023 – Men with aggressive recurrent prostate cancer who were given a combination therapy aimed at hormone...
Antibody-based immunotherapy shows promise in high-risk prostate cancer
CANCER DIGEST – May 14, 2023 – In the first clinical trial of an antibody-based immunotherapy drug to show promise in men with advanced,...
New combination therapy shows promise in advanced prostate cancer
CANCER DIGEST – April 1, 2023 – Preliminary results of a clinical trial shows that a combination of two oral drugs provides a significant...
Men who consume colorful diet have less prostate cancer risk
CANCER DIGEST – March 10, 2023 – In a first of its kind research analyzing micronutrients in blood, researchers have found that a...
Blood test combines PSA and epigenetics for diagnosing prostate cancer with 94 percent accuracy
CANCER DIGEST – Feb. 17, 2023 – Researchers have developed another new blood test that detected prostate cancer with 94 percent accuracy...
Men over 70 undergoing low-value prostate cancer screening
CANCER DIGEST – Jan. 4, 2023 – An analysis of Medicare data shows that men over 70 may be undergoing unnecessary prostate cancer...
